What Is the Glucose Challenge Test?

The Glucose Challenge Test (GCT) is a widely used screening tool designed to identify pregnant women who may have gestational diabetes mellitus (GDM). GDM is a condition characterized by high blood sugar that first appears or is recognized during pregnancy, typically in the second or third trimester. If left unmanaged, GDM can lead to significant health risks for both the mother and the developing baby, including preeclampsia, preterm birth, neonatal hypoglycemia, and excessive birth weight (macrosomia). Because early detection and intervention can dramatically improve outcomes, the GCT serves as a critical first step in prenatal diabetes screening.

It is estimated that gestational diabetes affects 6% to 9% of pregnancies in the United States, though rates vary by population and diagnostic criteria. The GCT is recommended for all pregnant individuals, regardless of prior risk factors, as many women who develop GDM have no apparent risk factors before pregnancy. The test is simple, non-invasive, and widely available, making it an efficient method for identifying those who need further diagnostic evaluation.

Understanding the Role of the GCT in Prenatal Care

The GCT is part of a two-step screening process commonly endorsed by the American College of Obstetricians and Gynecologists (ACOG) and the American Diabetes Association (ADA). It is performed between 24 and 28 weeks of gestation, a time when placental hormones begin to interfere with insulin action, increasing the risk of hyperglycemia. The test itself does not diagnose GDM; rather, it screens for abnormal glucose metabolism, flagging women who should proceed to the more definitive Oral Glucose Tolerance Test (OGTT).

Some clinicians may use a one-step approach (with a 75-gram OGTT that is both screening and diagnostic), but the two-step method using the 50-gram GCT remains the most common practice in the United States. Understanding which protocol your provider follows is important, as the thresholds and next steps differ. However, the GCT itself is always the initial screening component of the two-step strategy.

History and Evolution of GDM Screening

Large-scale screening for gestational diabetes emerged in the 1970s when researchers observed that women with undiagnosed hyperglycemia had poorer pregnancy outcomes. The original 100-gram, three-hour OGTT was cumbersome and time-consuming, leading to the development of the 50-gram, one-hour GCT as a simpler initial test. This approach was validated by landmark studies, including the 1979 O'Sullivan and Mahan criteria, which established blood glucose thresholds that have been refined over decades. Today, the GCT is a standard component of prenatal care in many countries, though some regions have shifted to universal testing with the one-step method.

How the Glucose Challenge Test Is Conducted

The GCT is straightforward and does not require fasting, contrary to some misconceptions. (Fasting is only needed for the OGTT that follows an abnormal GCT result.) Here is what a typical GCT appointment involves:

  • Preparation: You may be instructed to eat normally the day before and the morning of the test. However, some clinicians recommend avoiding large, sugary meals or heavy carbohydrate loads immediately before the test, as these could theoretically influence results. No fasting is required—stay hydrated with water.
  • Consuming the glucose drink: You will be given a beverage containing 50 grams of glucose. This solution is usually sweet, similar to a very sugary soft drink, and may be flavored (orange, lemon-lime, fruit punch). You must drink it within five minutes.
  • Waiting period: After finishing the drink, you will wait for exactly one hour. During this time, you should remain seated and avoid excessive activity. Light walking is usually permitted, but strenuous exercise could affect blood glucose levels. You cannot eat or drink anything other than small sips of water during the hour.
  • Blood draw: A blood sample is taken from a vein in your arm (or less commonly from a finger stick) 60 minutes after you finished the drink. The sample is sent to a lab to measure your plasma glucose level.

The test itself takes about 70–90 minutes total, including check-in, drinking, waiting, and the blood draw. Most women tolerate it well, though some may feel slightly nauseated or lightheaded due to the concentrated sugar solution. Inform your phlebotomist or nurse if you feel unwell.

Common Variations in Protocol

While the standard GCT uses 50 grams of glucose with a one-hour measurement, some clinics may use a slightly different protocol. For instance, a few institutions use a 75-gram, one-hour test as a screening, but that is less common. Additionally, women who are at very high risk for GDM (e.g., prior history, obesity, strong family history) may be screened earlier in pregnancy, sometimes at the first prenatal visit. If that early screen is normal, they are still retested at 24–28 weeks. Always confirm with your healthcare provider the specific protocol they follow.

Interpreting Glucose Challenge Test Results

The GCT result is a single number: your blood glucose level one hour after consuming the 50-gram glucose drink. Most laboratories and clinical guidelines use a cutoff of 140 mg/dL (7.8 mmol/L). However, some practices use a lower threshold of 135 mg/dL (7.5 mmol/L) to increase sensitivity, especially in populations with a higher prevalence of GDM. The interpretation is straightforward:

  • Normal (negative screen): Blood glucose below the chosen cutoff (commonly < 140 mg/dL). This result suggests that you are unlikely to have gestational diabetes, and no further testing is needed unless symptoms develop or you later develop risk factors.
  • Abnormal (positive screen): Blood glucose at or above the cutoff. This does not mean you have GDM; it indicates that you need further diagnostic testing, usually a 100-gram oral glucose tolerance test (or a 75-gram test in some settings) to determine whether GDM is present.

It is important to note that the GCT is not a diagnostic test. Roughly 15% to 20% of women will have a positive screen, but only about one-third of those will actually be diagnosed with GDM after the full OGTT. The GCT's cutoff is deliberately set low to maximize sensitivity—catching nearly all cases of GDM while accepting that many will have a false-positive screen. This is a conscious trade-off in public health screening.

What Does an Abnormal GCT Mean for You?

If your GCT result is abnormal, your provider will promptly schedule a diagnostic OGTT. This test requires fasting for at least 8 hours overnight, then drinking a 100-gram glucose solution (or 75 grams, depending on the protocol), with blood draws at fasting and at one, two, and three hours after drinking. Fasting glucose is measured, and if two or more values exceed defined thresholds, GDM is diagnosed. You will not be labeled as having GDM based on the GCT alone, so try not to worry—most women with a positive screen do not have diabetes.

Some clinicians also use a two-step process with a lower cutoff (e.g., 130 mg/dL) to increase the detection rate. In such cases, more women will be sent for the OGTT, but fewer cases of GDM will be missed. Discuss your individual cutoff and follow-up plan with your doctor.

Why the Glucose Challenge Test Matters: Clinical Importance

Untreated gestational diabetes can have serious consequences. High maternal blood sugar crosses the placenta, causing the fetal pancreas to produce excess insulin. This leads to accelerated fetal growth (macrosomia), which increases the risk of shoulder dystocia, cesarean delivery, and birth injury. Additionally, GDM is associated with a higher likelihood of preterm birth, neonatal hypoglycemia, jaundice, and respiratory distress syndrome. For the mother, GDM raises the risk of preeclampsia and future type 2 diabetes—over half of women with GDM will develop type 2 diabetes within 5–10 years.

Early detection through the GCT allows for timely intervention. Once GDM is confirmed, management typically includes dietary modifications, regular physical activity, blood glucose monitoring, and, if needed, insulin or oral medications. These interventions have been shown to reduce adverse outcomes significantly. A landmark study known as the HAPO (Hyperglycemia and Adverse Pregnancy Outcomes) study demonstrated a continuous relationship between maternal hyperglycemia and adverse outcomes, underscoring the value of screening.

The GCT is also an opportunity for patients to learn about their glucose metabolism and make healthy lifestyle changes that benefit not only the pregnancy but long-term health. Women diagnosed with GDM are often advised to undergo glucose testing 4–12 weeks postpartum and annually thereafter to monitor for progression to prediabetes or diabetes.

Risks, Side Effects, and Considerations

The Glucose Challenge Test is extremely safe and has no major medical risks. However, some women experience minor side effects related to the high sugar load:

  • Nausea – The concentrated sweetness can cause temporary nausea, especially if you have a sensitive stomach. Drinking the solution slowly (within the five-minute window) and keeping crackers or a light snack for after the test may help.
  • Lightheadedness or dizziness – A rapid rise in blood sugar can make some people feel dizzy or faint. If you have a history of vasovagal reactions or feel unwell, inform the staff and lie down until symptoms pass.
  • Headache – Some women report a mild headache after the drink, usually short-lived.
  • Unlikely allergic reactions – The glucose solution may contain synthetic flavors or dyes; reactions are exceedingly rare but possible. If you have known allergies, notify your provider.

The GCT should not be performed if you are actively ill with vomiting or unable to keep the drink down. It is also not recommended if you have a known diagnosis of diabetes already (type 1 or type 2), as the test is designed to screen for undiagnosed GDM. There are no absolute contraindications for the GCT in a healthy pregnant woman.

Alternatives to the GCT

In rare cases where the GCT cannot be performed (e.g., severe nausea, inability to tolerate the drink, or previous gastric bypass surgery), some providers may use alternative screening methods. These include monitoring fasting or postprandial blood glucose values over a week, or using a continuous glucose monitor (CGM) for a short period. However, these alternatives are less standardized and not considered first-line. Additionally, the one-step approach with a 75-gram, two-hour OGTT can serve as a combined screen and diagnostic test, though it requires fasting and is more burdensome.

Preparing for the Test: Practical Tips

To help ensure a smooth and accurate GCT experience, consider the following:

  • Schedule the test at a time that allows you to rest for one hour afterward. Avoid scheduling on a day when you have to rush or stand for long periods.
  • Eat a balanced meal several hours before the test. Avoid very high-carb or high-sugar foods immediately prior, but do not starve yourself. A normal breakfast or lunch is fine.
  • Drink plenty of water before and during the test (except during the waiting hour, when you should only take small sips if needed).
  • If you are prone to nausea, ask if the drink can be served chilled. Cold temperatures can sometimes reduce the sweet taste.
  • Bring something to read or a podcast to listen to during the waiting period.
  • Do not smoke or vape during the hour wait, as nicotine can affect blood sugar levels.
  • Inform the staff if you have any medical conditions (e.g., previous bariatric surgery, hypoglycemia episodes, or medication use) that might affect glucose metabolism.

When the GCT Result Is Normal: What Next?

If your glucose level is below the cutoff, no further testing for GDM is needed unless you develop symptoms or risk factors later in pregnancy. However, it is still important to attend all prenatal appointments and discuss any concerns. A normal GCT does not guarantee that you will not develop GDM later—but the peak risk period has passed. In rare cases, women with a normal early screen may be offered a repeat GCT if they develop classic symptoms such as polyuria, polydipsia, or excessive fetal growth on ultrasound. Some providers also recommend a second screen at 32–34 weeks for women with strong risk factors, though this is not standard.

When Results Are Abnormal: Navigating Follow-Up

Receiving an abnormal GCT result can be unsettling, but remember: it is not a diagnosis. Most women with a positive screen do not have GDM. The next step is the diagnostic OGTT, which is more rigorous but provides a definitive answer. Your provider will give you specific instructions, including fasting for 8–12 hours overnight (only water allowed) and arranging for a 2–3 hour visit at the lab. During the OGTT, blood is drawn before the drink and at specific intervals afterward. If GDM is diagnosed, you will be connected with a team of healthcare professionals (often including a diabetes educator, dietitian, and maternal-fetal medicine specialist) to develop a management plan tailored to your needs.

It is crucial not to ignore an abnormal GCT or postpone the OGTT. Diagnosing GDM earlier (even within the 24–28 week window) allows more time to initiate treatment and reduce complications. Studies show that tight glycemic control can bring perinatal outcomes to levels similar to those of women without GDM.

Special Populations and Considerations

Certain populations have higher baseline prevalence of GDM, including women of Hispanic, African American, Native American, South Asian, and Pacific Islander descent. In these groups, the GCT remains the recommended screening tool, but some institutions may use a lower cutoff (e.g., 130 mg/dL) to reduce missed diagnoses. Women over age 35, those with a prior history of GDM, or those with a first-degree relative with diabetes are also at increased risk and should be vigilant about screening. For women with a prior pregnancy affected by GDM, early screening at the first prenatal visit is often advised, with repeat testing at 24–28 weeks if the early result is normal.

In twin pregnancies, the GCT is still used, though some studies suggest that GDM rates are similar or slightly higher. Screening protocols for twins are generally the same as for singletons.

Conclusion

The Glucose Challenge Test is a simple, safe, and highly effective screening tool that has become a cornerstone of prenatal care. By identifying women who may have gestational diabetes, the GCT enables early management that can dramatically improve health outcomes for both mother and child. Understanding the process—from preparation to interpreting results—helps demystify the test and reduces anxiety. If you have questions or concerns about the GCT or GDM screening in general, talk with your healthcare provider. For more detailed clinical guidelines, refer to the ACOG Practice Bulletin on Gestational Diabetes Mellitus and the ADA Standards of Medical Care in Diabetes. Being informed empowers you to participate actively in your pregnancy care and take proactive steps for long-term health.